期刊文献+

炔雌醇醋酸环丙孕酮联合二甲双胍治疗肥胖型多囊卵巢综合征的疗效 被引量:74

Effects of ethinylestradiol and cyproterone acetate tablets combined with metformin in the treatment of obese women with polycystic ovary syndrome
原文传递
导出
摘要 目的观察炔雌醇环丙孕酮片联合二甲双胍治疗肥胖型多囊卵巢综合征的疗效。方法 58例多囊卵巢综合症患者,从自然月经或撤退性出血的5 d开始,每晚口服炔雌醇醋酸环丙孕酮,21 d为1个周期;治疗结束,撤退性出血第5d开始,进行下一个周期,连服3个月,同时服用二甲双胍500 mg,2次/日。服药3个月后,检查体重指数、治疗前后的卵泡刺激素(FSH)、促黄体激素(LH)及睾酮(T)。结果治疗前后,体重指数分别为(27.50±2.86),(25.1±4.0)kg.m-2,T分别为(2.74±1.57),(1.46±0.80)mmol.L-1,LH/FSH比值分别为3.41±2.20,1.78±1.20,均明显下降(均P<0.05)。结论炔雌醇醋酸环丙孕酮联合二甲双胍有效改善临床症状、内分泌水平、降低胰岛素抵抗及体重指数。 Objective To investigate the effects of ethinylestradiol and cyproterone acetate tablets combined with metformin in the treatment of obese women with polycystic ovary syndrome(PCOS).Methods Fifty-eight cases of obese women with PCOS were involved.From natural menstruation or retreat hemorrhages 5 d beginning,every night oral ethinylestradiol cyproterone acetate,21 d for a cycle.The end of treatment,retreat hemorrhages 5 d beginning,for the next cycle,at the same time was give metformin 500 mg,every time twice a day for 3 months.The body mass index(BMI),follicle-stimulating hormone(FSH),luteinizing hormone(LH),testosterone(T) were examined before and after treatment.Results BMI were(27.50±2.86),(25.1±4.0) kg·m-2;T were(2.74±1.57),(1.46±0.80) mmol·L-1;LH/FSH ratio were(3.41±2.20),(1.78±1.20) before and after treatment respectively.There were decreased significantly compared with before treatment(P0.05).Conclusion Ethinylestradiol and cyproterone acetate tablets joint metformin effectively improve clinical symptoms and endocrine level,reduced the insulin resistance and BMI.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2013年第3期175-176,共2页 The Chinese Journal of Clinical Pharmacology
关键词 多囊卵巢综合症 炔雌醇醋酸环丙孕酮 二甲双胍 polycystic ovary syndrome ethinylestradiol and cyproterone acetate tablets metformin
  • 相关文献

参考文献4

二级参考文献29

  • 1Moll E,Bossuyt PM,Korevaar JC,菅鑫妍.枸橼酸氯米芬加二甲双胍和枸橼酸氯米芬加安慰剂在新近诊断为多囊卵巢综合征妇女诱导排卵中的作用[J].中国处方药,2006,5(9):48-49. 被引量:23
  • 2Bahceci M, Tuzcu A, Bahceci S,et al. Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome[J]? J Endocrinol Invest, 2003,26(7) :655-659.
  • 3Dravecka I, Lazurova I, Kraus V. Obesity is major factor de terminning an insulin sensitivity and androgen production in women with anovulary cycles[J]. Bretisl Lek Listy, 2003,104(12) :393-399.
  • 4Wasko R, Komarowska H, Warenik-Szymankiewicz A, et al. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome[J]. Horm Metab Res, 2004, 36 (3): 170-173.
  • 5Amato G, Conte M, Mazziotti G,et al. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimula ted cycles[J]. Obstet Gynecol, 2003,101(6):1177-1182.
  • 6Cengiz C. The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligo menorrheic patients without PCOS[J]. Gynecol Endocrinol,2002,16(6): 447-452.
  • 7Hacihanefioglu B,Seyisoglu H,Karsidag K,et al. Influence of insulin resistence on total renin level in normotensive woman with polycystic ovary syndrome[J]. Fertil Steril, 2000,73 (2):261-265.
  • 8Minegishi T, Hirakawa T, Kishi H,et al. A role of insulin like growth factor 1 for follicle-stimulating hormone receptor expression in rat granulosa cells [J]. Biol Reprod, 2000, 62(2) :325-333.
  • 9Thierry van Dessel HJ, Lee PD, Faessen G,et al. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 1999,84 (9):3030-3035.
  • 10Endola KA, Zhou J, Adesanya OO, et al. Androgen stimu late early stages of follicular growth in the primate ovary[J].J Clin Invest,1998,101(12) :2622-2629.

共引文献33

同被引文献439

引证文献74

二级引证文献547

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部